Teladoc Health
TDOC
378 hedge funds and large institutions have $6.17B invested in Teladoc Health in 2019 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 135 increasing their positions, 122 reducing their positions, and 43 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
19% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 43
11% more repeat investments, than reductions
Existing positions increased: 135 | Existing positions reduced: 122
7% more capital invested
Capital invested by funds: $5.74B → $6.17B (+$428M)
5.28% more ownership
Funds ownership: 121.08% → 126.37% (+5.3%)
2% more funds holding
Funds holding: 371 → 378 (+7)
52% less call options, than puts
Call options by funds: $79.3M | Put options by funds: $165M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$189M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$59.8M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$38.6M |
| 4 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$37.5M |
| 5 |
BlackRock
New York
|
+$37.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$30.7M |
| 2 |
Janus Henderson Group
London,
|
-$29.5M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$27.8M |
| 4 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
-$23.4M |
| 5 |
PA
Perceptive Advisors
New York
|
-$20.4M |
TDOC Hedge Fund Activity: Q3 2019 in Review
378 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Teladoc Health (TDOC) for Q3 2019, worth a combined $6.17B — up 7.5% from $5.74B a quarter earlier.
Buyers outnumbered sellers: 51 funds opened new TDOC positions and 43 closed out — a net gain of 8 holders — while 135 added to existing stakes and 122 trimmed.
The largest buyer was Baillie Gifford & Co, adding an estimated $189M. The largest seller was Redmile Group, exiting entirely with an estimated $30.7M sold.
- 378 institutional investors held Teladoc Health (TDOC) as of Q3 2019, up from 371 in Q2 2019.
- Funds reported $6.17B of Teladoc Health stock for Q3 2019, up 7.5% quarter-over-quarter.
- 51 funds opened new Teladoc Health positions in Q3 2019 and 43 closed out, a net change of +8 holders.
- The largest Teladoc Health buyer in Q3 2019 was Baillie Gifford & Co, an estimated $189M added.
- The largest Teladoc Health seller in Q3 2019 was Redmile Group, an estimated $30.7M sold.
Based on aggregated 13F filings for Q3 2019.